Houston Rx Llc: Tirzepatide/niacinamide
Recall Summary Houston Rx LLC is recalling Tirzepatide/Niacinamide injectable vials (20mg/2mg per 2mL dose) distributed nationwide because the company cannot confirm the product was manufactured under sterile conditions. The affected vials were distributed across all U.S. states and Washington, D.C. This is classified as a Class II recall, meaning use of the product could cause serious adverse health effects or death.
- Recalling firm
- Houston Rx LLC
- Product
- Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.
- Reason
- Lack of assurance of sterility.
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-09-25
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide in the USA.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/4444e207-d22a-41dd-978a-84d35a9ce158